Effect of Abaloparatide on Lumbar Disc Degeneration
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Abaloparatide (Primary)
- Indications Back pain
- Focus Proof of concept; Therapeutic Use
- 18 Feb 2019 Last checked against ClinicalTrials.gov: US National Institutes of Health
- 11 Feb 2019 Planned End Date changed from 31 Dec 2022 to 31 Mar 2023.
- 11 Feb 2019 Planned primary completion date changed from 31 Jul 2021 to 30 Nov 2021.